Liraglutide was also shown to ameliorate cardiac hypertrophy potentially by suppressing the AT1R-mediated events and preventing the progression of cardiac hypertrophy to heart failure [160]. The gene discussed is AGTR1; the disease is cardiac hypertrophy.